Collection: Pharmacologically Active Metabolites
Pharmacologically Active Metabolites — a collection of active metabolite compounds derived from a parent compound, such as tizoxanide, teriflunomide, and tenofovir, which are studied because their chemical structure and pharmacokinetic properties differ from those of the original compound. This category is part of the Bioactive Compounds group, providing reference materials for metabolism and analytical research.
Metabolites in this category are used by analytical chemistry researchers as comparison standards for identifying and quantifying the metabolic pathways of a parent compound, for example via LC-MS/MS. Compounds such as abiraterone and acitretin also serve as structural reference materials in structure-activity relationship studies and in the development of analytical methods for related materials.
Example products in this collection: TCI T3862 173903-47-4 Tizoxanide, TCI D3793 71939-50-9 Dihydroartemisinin, TCI T3287 163451-81-8 Teriflunomide, TCI D5598 93413-62-8 O-Desmethylvenlafaxine, TCI T3006 147127-20-6 Tenofovir, TCI D6169 944-73-0 1,3-Dimethyluric Acid, TCI A3097 55079-83-9 Acitretin, TCI E0748 86639-52-3 7-Ethyl-10-hydroxycamptothecin.
Analytical purity and stereochemical identity (for metabolites with chiral centers) are key considerations, as these compounds are generally used as reference standards in quantitative analysis. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.
Other categories at the same level under Bioactive Compounds, often used together in a single laboratory workflow:
Back to Bioactive Compounds. For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — the official TCI Japan distributor in Indonesia — to check availability and lead time directly from Japan.
